| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MANNKIND CORP | Pres, Endocrine Business Unit | Common Stock, $0.01 Par Value | 333,429 | $1,520,436 | $4.56 | 14 May 2025 | Direct |
| MANNKIND CORP | Pres, Endocrine Business Unit | Performance Restricted Stock Unit | 1,000,000 | 23 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MNKD | MANNKIND CORP | 23 Jun 2025 | 1 | $0 | 4 | Pres, Endocrine Business Unit | 25 Jun 2025, 21:00 |
| MNKD | MANNKIND CORP | 14 May 2025 | 3 | +$99,996 | 4 | Pres, Endocrine Business Unit | 16 May 2025, 18:20 |
| MNKD | MANNKIND CORP | 12 Feb 2025 | 1 | $0 | 4 | Pres, Endocrine Business Unit | 13 Feb 2025, 21:30 |
| MNKD | MANNKIND CORP | 06 Jan 2025 | 0 | $0 | 3 | Pres, Endocrine Business Unit | 29 Jan 2025, 21:00 |